1a. Colorless prisms, m.p. 94–95 ◦C (lit.,10 92 ◦C).
125 (43), 91 (100). Anal Calcd for C16H13N2S3Cl: C, 52.66; H, 3.60;
N, 7.67; S, 26.36. Found: C, 52.96; H, 3.63; N, 7.45; S, 26.60.
1b. White prisms, m.p. 61–62 ◦C. IR (nujol) nmax: 3297, 1225,
1
H
1090, 842 cm-1. H NMR (CDCl3) d (ppm): 7.32 (d, 2H, J =
Crossed experiment for the synthesis of
3-alkyl-5-alkylthio-2-thioxo-1,3,4-thiadiazolines 3
8.47 Hz), 7.27 (d, 2H, J = 8.47 Hz), 4.27 (s, 2H, S-CH2), 3.84
(s, 3H, N-CH3), 3.73 (s, 2H, NH2). 13C NMR (CDCl3) d (ppm):
C
=
200.3 (C S), 134.1 (q), 133.6 (q), 130.6 (CH), 129.0 (CH), 38.8
A
suspension of equimolecular amounts of methyl 2-
(S-CH2), 36.9 (N-CH3). MS (EI): m/z (%): 246 (M+, 7), 127 (35),
125 (100), 89 (35). Anal Calcd for C9H11N2S2Cl: C, 43.80; H, 4.49;
N, 11.35; S, 25.99. Found: C, 43.45; H, 4.31; N, 11.06; S, 26.39.
methyldithiocarbazate 1a (5 mmol) and 4-chlorobencyl 2-
benzyldithiocarbazate 1d (5 mmol) in carbon disulfide (10 mL)
is heated at 125 ◦C for 48 h. On cooling, the mixture is evaporated
to dryness and the resulting solid is submitted to GC-MS analysis.
1c. White needles, m.p. 92–93 ◦C. IR (nujol) nmax: 3275,
H
1224 cm-1. 1H NMR (CD3CN) d (ppm): 7.21–7.01 (m, 5H), 5.20
(s, 2H, N-CH2), 4.26 (s, 2H, NH2), 1.92 (s, 3H, S-CH3). 13C NMR
Acknowledgements
C
=
(CD3CN) d (ppm): 200.1 (C S), 136.6 (q), 130.1 (CH), 129.5
We gratefully thank the grants from MICINN-Spain, Project
CTQ2008-01402 and Fundacio´n Se´neca project 04509/
GERM/06 (Programa de Ayudas a Grupos de Excelencia de
la Regio´n de Murcia, Plan Regional de Ciencia y Tecnolog´ıa
2007/2010).
(CH), 129.2 (CH), 61.0 (N-CH2), 20.5 (S-CH3). MS (EI): m/z
(%): 213 (M++1, 6), 121 (36), 91 (100). Anal Calcd for C9H12N2S2:
C, 50.91; H, 5.70; N, 13.19; S 30.20. Found: C, 50.85; H, 5.70; N,
13.07; S, 30.53.
1d. White prisms, m.p. 109–110 ◦C. IR (nujol) nmax: 3302, 1222,
H
1089, 854 cm-1. 1H NMR (CD3CN) d (ppm): 7.46–7.24 (m, 9H),
Notes and references
5.40 (s, 2H, N-CH2), 4.54 (s, 2H, NH2), 4.38 (s, 2H, S-CH2). 13
C
C
1 (a) V. S. Misra and N. S. Agarwal, J. Prakt. Chem., 1969, 311, 697;
(b) L. F. Awad and S. H. El Ashry, Carbohydr. Res., 1998, 312, 9;
(c) A. Varvaresou, T. Siatra-Papastaikoudi, A. Tsantili-Kakoulidou and
A. Vamvakides, Farmaco, 1998, 53, 320; (d) E. Palaska, G. Sahin, P.
Kelicen, N. T. Durlu and G. Altinok, Farmaco, 2002, 57, 101; (e) B. S.
Holla, K. N. Poorjary, B. S. Rao and M. K. Shivananda, Eur. J. Med.
Chem., 2002, 37, 511; (f) M. Amir and K. Shikha, Eur. J. Med. Chem.,
2004, 39, 535; (g) N. Demirbas, S. Alpay Karaoglu, A. Demirbas
and A. Sancak, Eur. J. Med. Chem., 2004, 39, 793; (h) S. Schenone,
C. Brullo, O. Bruno, F. Bondavalli, A. Ranise, W. Filippelli, B.
Rinaldi, A. Capuano and G. Falcone, Bioorg. Med. Chem., 2006, 14,
1698; (i) A.-R. Farghaly, E. De Clercq and H. El-Kashef, Arkivoc,
2006, (x), 137; (j) A. O. Abdelhamid and A. R. Sayed, Phosphorus,
Sulfur Silicon Relat. Elem., 2007, 182, 1767; (k) M. A. Devi and V. M.
Reddy, Asian J. Chem., 2008, 20, 5849.
2 (a) P. Molina, A. Ta´rraga and A. Espinosa, Synthesis, 1988, 690; (b) P.
Molina, A. Ta´rraga and A. Espinosa, Heterocycles, 1989, 29, 2301;
(c) P. Molina, A. Ta´rraga and A. Espinosa, Synthesis, 1989, 923; (d) P.
Molina, A. Ta´rraga, I. D´ıaz, A. Espinosa and C. Gaspar, Heterocycles,
1993, 36, 1263; (e) P. Molina, A. Ta´rraga, C. Gaspar and A. Espinosa,
J. Org. Chem., 1994, 59, 3665.
=
NMR (CD3CN) d (ppm): 200.2 (C S), 136.5 (q), 134.7 (q), 131.9
(q), 130.5 (CH), 128.5 (CH), 127.9 (CH), 127.6 (CH), 59.4 (N-
CH2), 39.5 (S-CH2). MS (EI): m/z (%): 197 (7), 159 (17), 157
(50), 148 (29), 127 (25), 125 (77), 121 (52), 91 (100). Anal Calcd
for C15H15N2S2Cl: C, 55.80; H, 4.68; N, 8.68; S 19.86. Found: C,
55.62; H, 4.70; N, 8.87; S 19.94.
General procedure for the synthesis of
3-alkyl-5-alkylthio-2-thioxo-1,3,4-thiadiazolines 3
A suspension of the appropiate alkyl 2-alkyldithiocarbazate 1
(10 mmol) in carbon disulfide (10 mL) is heated at 120 ◦C for 24 h.
On cooling, the mixture is evaporated to dryness and the resulting
solid is scratched with hexane, filtered off and crystallized from
ethanol.
3a. Yellow needles, m.p. 83–84 ◦C (lit.,3 84 ◦C).
3 P. Molina, A. Espinosa, A. Ta´rraga, F. Herna´ndez-Cano and M. C.
Foces-Foces, J. Chem. Soc., Perkin Trans. 1, 1991, 1159.
4 A. Espinosa, A. Frontera, R. Garc´ıa, M. A. Soler and A. Ta´rraga,
Arkivoc, 2005, (ix), 415.
5 L. Stryer, Biochemistry, 4th ed., Freeman: New York, 1995,
p 722.
◦
3b. Pale yellow prisms, m.p. 62–63 C. IR (nujol) nmax: 1596,
1258, 1091, 833 cm-1. H NMR (CDCl3) d (ppm): 7.24 (s, 4H),
1
H
4.21 (s, 2H, S-CH2), 3.77 (s, 3H, N-CH3). 13C NMR (CDCl3) d
C
(ppm): 185.6 (C2), 154.2 (C5), 134.2 (q), 133.6 (q), 130.1 (CH),
129.0 (CH), 38.8 (N-CH3), 37.0 (S-CH2). MS (EI): m/z (%): 290
(M++2, 8), 288 (M+, 17), 159 (2), 157 (6), 127 (39), 125 (100), 73
(11). Anal Calcd for C10H9N2S3Cl: C, 41.58; H, 3.14; N, 9.70; S,
33.30. Found: C, 41.30; H, 3.07; N, 9.69; S, 33.10.
6 (a) P. Velichkova and F. Himo, J. Phys. Chem. B, 2005, 109, 8216; (b) P.
Velichkova and F. Himo, J. Phys. Chem. B, 2006, 110, 16.
7 C. W. Blomstrand, J. Prakt. Chem., 1883, 27, 161.
8 For a review see:S. G. Murray and F. R. Hartley, Chem. Rev., 1981, 81,
365.
3c. Yellow oil. IR (nujol) nmax: 1604, 1186 cm-1. H NMR
1
9 (a) T. Weber, R. Prins, and R. A. van Santen, (ed.) Transition
Metal Sulfides; Kluwer: Dordrecht, The Netherlands, 1998; (b) T.
Kabe, A. Ishihara, and W. Quian, Hydrodesulfurization and Hy-
drodenitrogenation; Wiley-VCH: New York, 2000; (c) R. Sa´nchez-
Delgado, Organometallic Modelling of the Hydrodesulfurization and
Hydrodenitrogenation Reactions; Springer-Verlag: Berlin, 2002.
10 (a) M. A. Ali, S. E. Livingstone and D. J. Phillips, Inorg. Chim. Acta,
1972, 6, 11; (b) M. A. Ali and S. C. Teoh, J. Inorg. Nucl. Chem., 1978,
40, 451.
11 M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, M. A. Robb,
J. R. Cheeseman, J. A. Montgomery, Jr., T. Vreven, K. N. Kudin, J. C.
Burant, J. M. Millam, S. S. Iyengar, J. Tomasi, V. Barone, B. Mennucci,
M. Cossi, G. Scalmani, N. Rega, G. A. Petersson, H. Nakatsuji, M.
Hada, M. Ehara, K. Toyota, R. Fukuda, J. Hasegawa, M. Ishida, T.
Nakajima, Y. Honda, O. Kitao, H. Nakai, M. Klene, X. Li, J. E.
Knox, H. P. Hratchian, J. B. Cross, V. Bakken, C. Adamo, J. Jaramillo,
H
(CDCl3) d (ppm): 7.38–7.32 (m, 2H), 7.29–7.21 (m, 3H), 5.36 (s,
2H, N-CH2), 2.50 (s, 3H, S-CH3) 13C NMR (CDCl3) d (ppm):
C
185.4 (C2), 156.4 (C5), 134.6 (q), 128.7 (CH), 128.5 (CH), 128.2
(CH), 53.9 (N-CH2), 15.4 (S-CH3). MS (EI): m/z (%): 254 (M+,
18), 181 (3), 149 (6), 148 (81), 91 (100). Anal Calcd for C10H10N2S3:
C, 47.21; H, 3.96; N, 11.01; S, 37.81. Found: C, 47.34; H, 3.96; N,
11.32; S, 38.07.
◦
3d. White flakes, m.p. 75–76 C. IR (nujol) nmax: 3303, 1601,
1221, 1089, 854 cm-1. 1H NMR (CDCl3) d (ppm): 7.40–7.23 (m,
H
9H), 5.45 (s, 2H, N-CH2), 4.40 (s, 2H, S-CH2). MS (EI): m/z (%):
366 (M++2, 0.5), 364 (M+, 2), 159 (2), 157 (7), 148 (9), 127 (12),
This journal is The Royal Society of Chemistry 2010
Org. Biomol. Chem., 2010, 8, 1623–1628 | 1627
©